REDWOOD CITY, Calif., April 20, 2016 (GLOBE NEWSWIRE) -- OncoMed Pharmaceuticals Inc. (NASDAQ:OMED), presented ...
U.S. Clinical Study Sites Enrolling Patients with Systemic Oxalate Burden; European Sites Prepared to ...
ASTRAZENECA ENTERS LICENSING AGREEMENTS WITH LEO PHARMA IN SKIN DISEASES Agreement for development and ...
